NCT03795038View on ClinicalTrials.gov

Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 28, 2018

Primary Completion Date

May 25, 2021

Study Completion Date

May 25, 2021

Conditions

Hypercholesterolemia, FamilialDyslipidemiasCardiovascular Diseases

Interventions

DEVICE

Lipoprotein Apheresis MONET and DALI

Three apheresis treatments assigned to one type of apheresis system of MONETand DALI

DEVICE

Lipoprotein Apheresis DIAMED and DALI

Three apheresis treatments assigned to one type of apheresis system of DIAMOND and DALI

Trial Locations (2)

18059

Nephrocare Rostock GmbH, Rostock

01307

Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden

All Listed Sponsors

lead

Fresenius Medical Care Deutschland GmbH

INDUSTRY

NCT03795038 - Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI | Biotech Hunter | Biotech Hunter